Ankur Drugs & Pharma Limited(BSE:531683 NSE:ANKURDRUGS) ,Company Snapshot, Recent Developments, Latest News, Financials, Price Charts, Ratios, Contact Information

Shares Homepage - BSE Sensex, NSE Nifty, Latest Prices, Live News, Company Search, Result Annoucements, Company News, Top stories, Gainers Losers, Top Performers, Market Commentary, Live Quotes, Bulk Deals

Home

News Centre

IPO

Markets	Companies	Research	Industries	E-Mail Page

my Last 5 Scrips
Company	BSE Price(Rs)	% Chg
Tata Mot	302.40	0.31
Bhel	201.90	0.27
Tata Stl	315.30	9.88
Reliance	830.90	0.42
I T C Lt	334.65	0.01
Clear All	Clear Last

NSE Live
Nifty Live Prices Live Quotes Top Gainers/Losers Top 10 Turnover No Delivery Stocks

BSE Live
BSE30 Live Prices Live Quotes Top Gainers/Losers Top 10 Turnover No Delivery Stocks

Market Pulse
Leaders Laggards FII Activity Mutual Fund Activity Meetings

Results Watch
Results Calendar Results Announced

IPO Watch

Company
Snapshots Quotes Charts Financials Recent News Broker Research Meetings Research Tutorial Discussion Forum

Research
Research Reports

Sector Watch

Economy Watch

Snapshot-Ankur Drugs & Pharma Limited

Ankur Drugs & Pharma Limited

Sector:Pharmaceuticals Pharmaceuticals - Bulk Drugs
BSE:531683	NSE:ANKURDRUGS	Bloomberg:MRP@IN	Reuters:ANDP.BO
Market Lot: 1	Face Value: 10	ISIN Demat: INE238D01012

Quotes	Snapshot	Charts	Financials	Research	Recent News
Peer Group	AGM/AM	MF Holding	Discussion Forum	BSE/NSE Notices	BSE/NSE Deals

Recent Developments
23-NOV-10 Citigroup Global Markets Mauritius (P) has bought 1.52% stake in the company.Citigroup Global Markets Mauritius (P) bought 3.1 million shares at Rs 146.87 a share on Tuesday through bulk deal. 13-AUG-10 Amtek continued on the recovery path, with sales and profit growing for the third consecutive quarter. The broking firm expects domestic demand to be the key driver for Amtek going forward as well. Amtek`s overseas operations GWK, ... More..
Business Profile	Future Plans

One To One

Latest News

Ankur Drugs rebounds from low as foreign bank hikes stake -IRIS 17-Aug-10

Brief Financials (in Rs. Mn.)

Period ending (months)	31-Dec-2012(9)	31-Mar-2012 (12)	31-Mar-2011 (12)
Net sales	1047.00	1511.12	8239.97
Other Income	0.42	1.86	8.10
Total Income	1047.42	1512.98	8248.07
Cost of goods sold	1101.32	1793.95	6913.08
OPBDIT	-53.90	-280.97	1334.99
PAT	-1278.02	-3074.94	-651.30
Gross Block	-	-	-
Equity capital	193.42	193.42	193.42
EPS (Rs.)	-	-158.98	-33.67
DPS (Rs.)	-	-	-
BV (Rs.)	-	-	-
P/E range (x)	-	NA	NA
Debt / Equity (x)	-	-	-
Operating margin (% of OI)	-5.1	-18.6	16.2
Net margin (% of OI)	-122.0	-203.2	-7.9